Rabiya S Tuma

Efforts aimed at reducing noise, data overload in microarrays.

Rabiya S Tuma, 2005, Journal of the National Cancer Institute.

Biomarker developers face big hurdles.

Rabiya S Tuma, 2008, Journal of the National Cancer Institute.

Disease progression in some cancers may be due to low blood levels of targeted therapies.

Rabiya S Tuma, 2008, Journal of the National Cancer Institute.

Sometimes size doesn't matter: reevaluating RECIST and tumor response rate endpoints.

Rabiya S Tuma, R. Tuma, 2006, Journal of the National Cancer Institute.

Multiple gene signatures aim to qualify risk in breast cancer.

Rabiya S Tuma, 2005, Journal of the National Cancer Institute.

Origin of ovarian cancer may have implications for screening.

Rabiya S Tuma, R. Tuma, 2010, Journal of the National Cancer Institute.